SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DePhyneAI is a decentralized physical AI infrastructure enabling autonomous devices such as drones, robots, and edge sensors to perform intelligent tasks while earning rewards in the native token, $DPHY. The network is permissionless, community-owned, and designed to bring scalable, secure AI computation to the edge of the real world.  1. Introduction Artificial Intelligence has historically been confined to centralized cloud platforms. However, as physical devices grow more capable, the future lies in enabling intelligence directly on the edge - embedded in the real world. DePhyneAI empowers a decentralized network of autonomous agents to train, infer, and collaborate - creating a self-sustaining AI ecosystem governed by a native token economy.  What is DePhyneAI? DePhyneAI is an open, decentralized network where physical devices act as nodes. Each device contributes compute, data, or services and is rewarded in $DPHY tokens. The network supports:  Federated learning and on-device AI inference Secure blockchain-based coordination Real-time decision-making in physical environments Use Cases DePhyneAI supports diverse real-world applications:  Logistics: AI-enabled autonomous drone deliveries Agriculture: Monitoring soil, crop health, irrigation using robotic systems Smart Cities: Surveillance, traffic analysis, energy optimization Disaster Response: Real-time aerial monitoring and situational AI Why $DPHY Matters The $DPHY token is the lifeblood of the DePhyneAI network. It serves multiple purposes:  Rewards: Earned by node operators who run AI tasks Access: Used to access AI models, data feeds, and services Governance: Voting and proposal mechanisms Staking: Ensures quality and uptime guarantees

DePhyneAI

DePhyneAI ($DPHYAI.X) is trending as part of the AI crypto wave, with community members actively discussing its potential within the Phantom wallet ecosystem. Some users are highlighting its microcap status and potential for growth, while others urge caution, referencing previous hyped tokens. The focus remains on $DPHYAI.X's role in the broader AI narrative within the crypto space.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins ($PENGU.X) is trending amid discussions about its potential for growth and comparisons to other meme coins like $DOGE.X. Community members are actively debating entry points, expressing both bullish sentiment and frustration with recent price action, while also anticipating potential catalysts like a PENGU ETF.

Cognizant Technology Solutions Corp. engages in providing information technology, consulting, and business process outsourcing services. Its services include application services, artificial intelligence, business process services, cloud solutions, and core modernization. It operates through the following segments: Financial Services (FS), Healthcare Sciences (HS), Products and Resources (P and R), and Communications, Media, and Technology (CMT). The FS segment focuses on banking and insurance services. The HS segment is involved in healthcare and life sciences. The P and R segment includes retail and consumer goods. The CMT segment relates to communications, information, media and entertainment, and technology. The company was founded by Wijeyaraj Kumar Mahadeva and Francisco D'Souza on April 6, 1988 and is headquartered in Teaneck, NJ.

Cognizant Technology Solutions Corp. - Ordinary Shares - Class A

Cognizant ($CTSH) is trending amid discussions about the potential impact of H-1B visa fee changes and wage rule revisions on its business. Some community members are weighing the impact of AI on the IT services sector, considering both short-term revenue compression and long-term opportunities for high-margin AI solutions. Recent analyst ratings and price target adjustments are also contributing to the stock's activity.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta ($KTA.X) is trending as the community anticipates the mainnet launch, with some speculating it could be a "sell the news" event while others remain optimistic. Discussions center around its potential to revolutionize finance and unify blockchains, comparing it to established players like XRP and ETH.  Enthusiasm is fueled by its high TPS and Google's involvement, with many seeing a long-term potential.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co.

Disney is trending due to controversy surrounding Jimmy Kimmel's show suspension, sparking intense debate about freedom of speech and potential political influence. The community is actively discussing boycotts and subscription cancellations, while others defend Disney's decision. Some see this as an opportunity for short-term gains, while long-term investors remain divided about the impact on Disney's brand and future.

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication; Energy, Utilities, Resources, and Services; Manufacturing, Hi-Tech, Life Sciences, and All Other. The company was founded by Dinesh Krishnan Swamy, Senapathy Gopalakrishnan, Narayana Ramarao Nagavara Murthy, Raghavan N. S., Ashok Arora, Nandan M. Nilekani, and S. D. Shibulal on July 2, 1981 and is headquartered in Bangalore, India.

Infosys Ltd - ADR

Infosys Technologies Limited

Infosys ($INFY) is trending due to discussions around potential impacts from new visa fee regulations and recent collaborations. The community is weighing the implications of a possible $100,000 H-1B visa fee on the company's margins and its reliance on Indian talent. At the same time, new partnerships, such as the one with Mastercard to scale cross-border payments, and a recent buyback announcement are also focal points for investors.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT.X) is trending due to its recent listing on major exchanges like Binance and Coinbase, sparking significant community excitement and high trading volume. Some users are drawing comparisons to other successful projects, such as $HYPE.X and $MYX.X, while highlighting the backing from prominent investors like Peter Thiel and Pantera Capital.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

FLGC is trending as community members discuss its potential, especially in relation to cannabis rescheduling and the company's crypto holdings. Some are speculating about upcoming revenue and potential for significant gains, while others are focused on compliance with Nasdaq listing standards and possible reverse splits. The stock's low float and recent news regarding funding and private placements are also driving interest.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma ($ALMU) is trending as investors discuss a recent stock offering and its potential impact on the company's future. Community members are debating whether the offering was a strategic move to secure funding for upcoming commercial deals, particularly in the defense and aerospace sectors. Bullish sentiment revolves around confidence in the company's technology and its potential to disrupt the semiconductor industry, while some express concern over dilution and the offering's price.

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.

MiNK Therapeutics Inc

MiNK Therapeutics is trending due to the company's announcement of a grant-funded clinical trial for graft-versus-host disease and the appointment of Dr. Terese Hammond to lead inflammatory and pulmonary disease efforts. While some community members express skepticism, others are optimistic about the potential of iNKT cell therapies and the possibility of partnerships, leading to speculation about a potential short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jumia Technologies AG (JMIA) received a major upgrade from RBC Capital Markets after meetings with company leadership, which boosted confidence in its outlook.&nbsp;RBC upgraded the stock to ‘Outperform’ from ‘Sector Perform’ and lifted the price target to $15 from $6.50, citing improved supply conditions and weakening currency pressures as key positives, according to Thefly.&nbsp;&nbsp;<a href="https://stocktwits.com/symbol/JMIA">Jumia Technologies' stock</a> traded over 21% higher by Tuesday afternoon. On Stocktwits, retail sentiment around the stock jumped to ‘extremely bullish’ from ‘bullish’ territory the previous day. Message volume improved to ‘extremely high’ from ‘high’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:932/111;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_16_133025_png_6fd5fb61a1.webp" alt="JMIA’s Sentiment Meter and Message Volume as of 01:15 p.m. ET on Sep. 16, 2025 | Source: Stocktwits" width="932" height="111"><figcaption>JMIA’s Sentiment Meter and Message Volume as of 01:15 p.m. ET on Sep. 16, 2025 | Source: Stocktwits</figcaption></figure>The stock experienced a 775% increase in user message count&nbsp;over 24 hours, as of Tuesday morning.&nbsp;A Stocktwits user commended the stock’s gain since June.&nbsp;<stembedurl>https://stocktwits.com/stock_head/message/628849884</stembedurl>RBC’s bullish stance follows virtual meetings with Jumia’s CEO and CFO, where management appeared “incrementally positive” about the company’s ability to benefit from easing foreign exchange headwinds.&nbsp;The firm believes there’s room for upside as Jumia scales its operations with supply expansion and a boost in order growth.&nbsp;RBC expects Jumia to strengthen its relationships and gain momentum with Chinese suppliers.Jumia is one of Africa’s top e-commerce platforms. It runs its own delivery network, called Jumia Logistics, and offers digital payments through JumiaPay.&nbsp;The company’s second-quarter (Q2) revenue of $45.6 million exceeded the analyst consensus estimate of $44.8 million, according to Fiscal AI data. The Gross Merchandise Value (GMV) for Q2 rose 6% year-over-year to $180.2 million.&nbsp;Jumia Technologies’ stock has gained over 213% year-to-date and over 161% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/turbo-energy-stock-shots-up-over-460-percent-to-hit-a-record-high-today/chwyFY3Rdzq">Turbo Energy Stock Shoots Up Over 460% To Hit A Record High Today – Find Out More</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Jumia Technologies will be issuing over 20.22 million American Depositary Shares turning Wall Street against it.

Jumia Technologies Stock Jumped 21% Today After A Major Wall Street Upgrade – Check Out The New Price Target

RBC upgraded the stock to ‘Outperform’ from ‘Sector Perform’ and lifted the price target to $15 from $6.50, citing improved supply conditions and weakening currency pressures.

Equity

RBC upgraded the stock to ‘Outperform’ from ‘Sector Perform’ and lifted the price target to $15 from $6.50, citing improved supply conditions and weakening currency pressures.


Rocket Lab (RKLB) experienced a more than 700% increase in retail user message count on Stocktwits over the last 24 hours as of Wednesday morning, and was the top-trending stock on the platform.Retail sentiment on <a href="https://stocktwits.com/symbol/RKLB">Rocket Lab</a> improved to ‘extremely bullish’ from ‘bullish’ territory a day ago, with message volumes at ‘high’ levels, according to data from Stocktwits.<figure class="image"><img style="aspect-ratio:796/107;" src="https://news.stocktwits-cdn.com/RKLB_sentiment_png_2310e5aede.webp" alt="RKLB sentiment.png" width="796" height="107"><figcaption>RKLB sentiment and message volume September 3, 2025, as of 1:10 pm ET | Source: Stocktwits</figcaption></figure>The stock's watchlist count on Stocktwits doubled to 43,281 in a year.Notably, the company's shares declined 10% by midday trading on Wednesday, despite no stock-specific news. The shares appear to have taken a breather following the massive rally seen over the last year. Rocket Lab shares have gained 75% this year and have jumped over 600% over the previous 12 months.Last week, Roth Capital also raised its price target on Rocket Lab to $60 from $50 and maintained a ‘Buy’ rating, according the TheFly. The firm noted that it was impressed by Rocket Lab's progress toward the initial Neutron launch.The Neutron support infrastructure and launch pad infrastructure are all in place for initial launch, Roth Capital said. Rocket Lab opened Launch Complex 3 on August 28, its dedicated test, launch, and landing facility for its reusable rocket, Neutron. The pad is located within the Virginia Spaceport Authority’s (VSA) Mid-Atlantic Regional Spaceport (MARS) at Pad 0D on Wallops Island, Virginia.The company stated that Launch Complex 3 is poised to deliver the largest orbital launch capacity in the Spaceport’s history with Neutron, which is capable of launching 13,000 kg to space for commercial constellations, national security, and interplanetary missions, as well as eventually supporting human spaceflight.In late August, Rocket Lab&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rklb-stock-lifts-off-10-after-70th-electron-launch/chssMD9RdSc">launched</a> its 70th Electron mission as part of its ‘Live, Laugh, Launch’ mission.&nbsp;The ‘Live, Laugh, Launch’ was Electron’s 12th mission of 2025 as Rocket Lab continues to execute an accelerated schedule of Electron launches.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/campbells-ceo-flags-consumer-caution-sees-surge-in-home-cooking/chwcc2mRdoR">Campbell’s CEO Flags Consumer Caution, Sees Surge In Home Cooking And Wellness Demand</a>

Rocket Lab’s 360% surge so far in 2024 has brought CEO Peter Beck’s 10% stake in the company to $970 million. | Source: Rocket Lab USA 

This Aerospace Stock Witnessed A 700% Explosion In Retail Chatter On Stocktwits – More Details Inside

Last week, Roth Capital raised its price target on Rocket Lab to $60 from $50 and noted that it was impressed by the company’s progress toward the initial Neutron launch.

Autonomous driving technology company Mobileye Global Inc. (MBLY) on Thursday increased its full-year revenue guidance and lowered its operating loss forecast, citing continued strength in supply-demand dynamics and increased demand for its autonomous driving chips.“Stronger visibility on industry supply-demand alignment since late-April supports our decision to raise the full-year outlook, while we continue to maintain a conservative stance given the broader macro environment,” <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.mobileye.com/news-releases/news-release-details/mobileye-releases-second-quarter-2025-results-updates-full-year">said</a> Mobileye President and CEO Amnon Shashua, while also predicting an “inflection” in the company’s growth trajectory in 2027.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/MBLY">Mobileye</a> jumped from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:623/60;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_24_at_8_53_36_AM_png_4bc34a33af.webp" alt="MBLY's Sentiment Meter and Message Volume as of 8:53 a.m. ET on July 24, 2025 | Source: Stocktwits" width="623" height="60"><figcaption>MBLY's Sentiment Meter and Message Volume as of 8:53 a.m. ET on July 24, 2025 | Source: Stocktwits</figcaption></figure> The company now expects revenue of $1.77 billion to $1.89 billion for the full year 2025, up from its previous guidance range of $1.69 billion to $1.81 billion.Operating loss is expected to be between $512 million and $436 million for the year, which is narrower than the company’s previous estimate of $574 million to $489 million in operating loss.The company stated that the new guidance includes its estimates of production impacts related to current tariffs imposed on complete vehicles imported into the United States, as well as tariffs on imported vehicle components used in U.S. vehicle production. However, the company said it assumes no further tariff developments or increases.For the second quarter, the company reported a 15% increase in revenue to $506 million, surpassing an analyst estimate of $495.91 million, according to data from Fiscal AI. The company attributed the rise in revenue to strong demand for its EyeQ System-on-Chip, a custom hardware and software solution designed explicitly for Advanced Driver Assistance Systems (ADAS) and self-driving systems.Adjusted earnings per share came in at $0.13, compared to $0.09 in the corresponding quarter of 2024, and above an expected $0.11.A Stocktwits user opined that the stock is still a “bit expensive” and added that they would like a cheaper entry point.<stembedurl>https://stocktwits.com/eskitrades/message/622241885</stembedurl>&nbsp;&nbsp;Mobileye had $1.7 billion of cash and cash equivalents and zero debt as of June 28, 2025.MBLY stock is down by 20% this year and by about 29% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-registrations-slump-in-europe-yet-again-in-june/ch8ywW1R5HO">Tesla Registrations Slump In Europe Yet Again In June: Retail Sentiment Slips Amid 289% Jump In Chatter</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Mobileye Global, Inc. logo appears on a smartphone screen in this illustration photo in Reno, United States, on December 23, 2024. (Photo by Jaque Silva/NurPhoto via Getty Images)

Mobileye CEO Sees Inflection In 2027 Growth Trajectory As Company Hikes Full-Year Revenue Outlook: Retail Thinks Stock Is Still A ‘Bit Expensive’

The company stated that the new guidance includes its estimates of production impacts related to current tariffs imposed on complete vehicles imported into the United States and tariffs on imported vehicle components used in U.S. vehicle production. 

Vertiv Holdings (VRT) surged more than 13% on Wednesday after the AI infrastructure firm raised its full-year guidance and signaled confidence in managing new tariffs under President Donald Trump’s trade policy.First-quarter (Q1) earnings came in at $0.64 per share, slightly above the $0.62 consensus estimate, according to Koyfin. Revenue for the quarter rose 24% year-over-year (YoY) to $2.04 billion, beating Wall Street’s $1.94 billion forecast. Organic net sales climbed 25%.The maker of power and cooling equipment for data centers said it now expects full-year 2025 revenue between $9.325 billion and $9.575 billion, up from its prior range of $9.125 billion to $9.275 billion.&nbsp;“We’re seeing accelerated scaling of AI deployments across the data center market,” said CEO Giordano Albertazzi. “Our partnership with Nvidia continues to place us at the heart of industrial-scale AI factory deployments.”He added that the updated forecast takes into account the anticipated impact of new U.S. tariffs, which have become a growing concern for manufacturers with global supply chains.“Although the tariff environment remains fluid, our goal is to significantly mitigate the effect of tariffs as we enter 2026,” he stated, adding that the company is working to mitigate the tariff impact through operational flexibility, a diversified manufacturing footprint, and commercial strategy shifts.The company said it continues to shift production to Mexico under the USMCA trade framework, and said only a single-digit percentage of its U.S. factory inputs currently come from China. Vertiv said it aims to have all U.S.-bound components manufactured in Mexico.Despite Wednesday’s rally,&nbsp;<a href="https://stocktwits.com/symbol/VRT">Vertiv’s stock</a> remains down more than 30% year-to-date, though it has held a 4% gain over the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ge-vernova-cfo-sees-no-material-impact-from-trump-tariffs-on-outlook-q1-2025-earnings/chQmzXGRbgO">GE Vernova CFO Sees No ‘Material Impact’ From Trump Tariffs On Outlook – Stock Surges On Q1 2025 Earnings Beat</a>&nbsp;

In this photo illustration, the logo of Vertiv Holdings Co is displayed on a smartphone screen on April 20, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

Vertiv Stock Surges On Q1 Beat, Improved 2025 Outlook — CEO Says Trump Tariff Impact Will Be Mitigated By 2026

The company now expects full-year 2025 revenue between $9.325 billion and $9.575 billion, up from its prior guidance of $9.125 billion to $9.275 billion. 

Oklo’s (OKLO) stock&nbsp;gained 0.7% in pre-market trade&nbsp;on Wednesday, reversing an earlier 3%&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/oklo-stock-slips-after-sam-altman-steps-down-as-chair/chQmNFmRbXx">drop</a> after the company announced that co-founder Sam Altman would step down as chairman.&nbsp;The news, while initially surprising to investors, may pave the way for a key energy deal with OpenAI, according to Citi analysts.In a research note cited by TheFly, Citi highlighted the leadership change as a potential catalyst for Oklo’s long-term prospects.&nbsp;While Altman’s “abrupt departure” caught investors off guard, Citi believes it could resolve any conflict of interest related to Oklo’s ongoing discussions with OpenAI about a potential energy supply agreement.&nbsp;The brokerage noted that given Altman’s dual roles at both Oklo and OpenAI, his exit could clear the path for a more strategic partnership in the future.Citi maintained its ‘Neutral’ rating on&nbsp;<a href="https://stocktwits.com/symbol/OKLO">Oklo’s stock</a>, with a $30 price target, noting that the company has been actively seeking new board members and considering the separation of the CEO and chairman roles.&nbsp;Analysts expect the initial market reaction to be negative, but they emphasized that a deal with OpenAI could alleviate these concerns, driving positive sentiment and potential stock upside.Meanwhile, H.C. Wainwright initiated coverage of Oklo with a ‘Buy’ rating and $55 price target, pointing to the company’s growing pipeline in advanced nuclear technology.&nbsp;It noted that Oklo has secured a 14 gigawatt (GW) pipeline, including a 12GW agreement with Switch, a data center developer, that extends through 2044.Oklo’s stock has gained 1.4% year-to-date and surged over 70% in the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/oklo-stock-slips-after-sam-altman-steps-down-as-chair/chQmNFmRbXx">Oklo Stock Slips After Sam Altman Steps Down As Chair, But Retail Sentiment Flips To 'Bullish'</a>

Sam Altman, former co-founder and CEO of OpenAI, speaks during a panel discussion titled "The Age of AI" at the Technical University of Berlin on February 07, 2025 in Berlin, Germany. (Photo by Sean Gallup/Getty Images)

Oklo-OpenAI Energy Deal More Likely After Sam Altman Exit, Says Citi

Citi noted that given Altman’s dual roles at both Oklo and OpenAI, his departure could pave the way for a more strategic partnership in the future.

Upstart Holdings Inc (UPST) shares surged about 26% in the after-market trade on Tuesday after the company posted a surprise profit and its fourth-quarter revenue beat Wall Street’s estimates.On an adjusted basis, the company posted earnings of $0.26 per share for the three months ended Dec. 31, compared with average analysts’ estimate of a loss of $0.15 per share.According to Koyfin data, the company reported quarterly revenue of $218.96 million, compared with the average analysts’ estimate of $181.92 million.Its net loss narrowed to $2.8 million, compared with $42.4 million in the same period last year.Upstart’s total loans jumped to 245,663 from 129,664 in the year-ago quarter, while its transaction volumes rose 66% to $2.1 billion.Its revenue from fees rose to $199.28 million from $152.86 million last year.The company expects to post $1 billion in revenue in 2025, which, if it meets its projections, will be a record annual revenue for the AI lending platform.Upstart also forecast a net interest income (NII) of about $80 million in 2025 and said it expects to at least break even this year. The company last posted a net profit in 2021.“In Q4 of 2024, our business grew dramatically across all product categories, delivered Adjusted EBITDA at levels not seen since the first quarter of 2022, and came within a whisker of returning to GAAP profitability,” CEO Dave Girouard said. &nbsp;Retail sentiment on Stocktwits moved higher in the ‘extremely bullish’ (96/100) territory, while retail chatter was ‘extremely high.’<figure class="image"><img style="aspect-ratio:803/184;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/UPST_Feb_12_d313e05882.JPG" alt="UPST’s Sentiment Meter and Message Volume as of 01:34 a.m. ET on Feb. 12, 2025 | Source: Stocktwits" width="803" height="184"><figcaption>UPST’s Sentiment Meter and Message Volume as of 01:34 a.m. ET on Feb. 12, 2025 | Source: Stocktwits</figcaption></figure>Users speculated if the stock could hit $350 soon, a level it last touched in 2021.<stembedurl>https://stocktwits.com/Koapark/message/603873161</stembedurl><stembedurl>https://stocktwits.com/drabon74/message/603874169</stembedurl>Over the past year, <a href="https://stocktwits.com/symbol/UPST">Upstart stock</a> has nearly doubled.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/energy-transfer-stock-falls-after-market-on-q4-revenue-miss-retail-shrugs-it-off/ch5aJ3ERub">Energy Transfer Stock Falls After-market On Q4 Revenue Miss: Retail Shrugs It Off</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Upstart Holdings logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Upstart Holdings Stock Soars Aftermarket After Surprise Q4 Profit: Retail’s Exuberant

On an adjusted basis, the company posted earnings of $0.26 per share for the three months ended Dec. 31, compared with average analysts’ estimate of a loss of $0.15 per share.

Shares of Cassava Sciences, Inc. (SAVA), a small-cap biotech firm, rose more than 5% on Tuesday after the company’s CEO, Rick Barry, provided an update on its Alzheimer’s drug trial via a regulatory 8-K filing.Barry announced that the ReTHINK Phase 3 clinical trial recently completed its final patient visit, marking a significant milestone in the development of Simufilam, a drug targeting a unique protein misfolding pathway associated with Alzheimer’s disease.Unlike traditional therapies that focus on amyloid plaques, Simufilam aims to correct the shape of the protein Filamin A, potentially addressing various Alzheimer’s disease processes.The ReTHINK trial enrolled 804 patients across 77 sites in the U.S., Puerto Rico, Canada, and Australia, with participants randomized between placebo and simufilam (100 mg twice daily). Approximately 70% of patients entered the study with mild Alzheimer’s, while the remaining 30% had moderate Alzheimer’s.Barry stated, “We expect to announce top-line results of the ReTHINK trial before year-end.” He mentioned that the proposed Statistical Analysis Plan was submitted to the FDA in July and is currently under review.Despite the positive news, retail sentiment on Stocktwits shifted from ‘bullish’ to ‘neutral’ after the update as of 1:00 pm ET. Cassava stock was the top trending ticker at 12:30 pm ET on Tuesday.<stembedurl>https://stocktwits.com/Tiffiny/message/588297923</stembedurl><stembedurl>https://stocktwits.com/Donniechen12345/message/588323050</stembedurl>The company had recently reached a $40 million settlement with the U.S. Securities and Exchange Commission (SEC) related to misleading claims about its Alzheimer’s drug trials, which had drawn considerable attention from retail investors.Following the CEO’s update, H.C. Wainwright upgraded Cassava Sciences to ‘Buy’ from ‘Neutral’, raising its price target to $116.The analyst believes the settlement has mitigated long-term challenges for the stock and anticipates a positive catalyst from the upcoming topline readout from the ReTHINK trial.Year-to-date, SAVA stock has climbed over 18%.For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next: <a href="https://stocktwits.com/news-articles/markets/equity/ww-stock-rises-on-compounded-glp1-drug-offering/cJchFDeREX">WeightWatchers Stock Rallies After Adding Compounded Semaglutide To Offerings Amid GLP-1 Shortages: Retail Stays Cautious</a> &nbsp;

Cassava's simufilam aims to correct the shape of the protein Filamin A, potentially addressing various Alzheimer’s disease processes. 

Cassava Sciences Stock Jumps After CEO’s Update On Alzheimer’s Drug Trial: Retail Sentiment Wavers

The ReTHINK trial enrolled 804 patients across 77 sites in the U.S., Puerto Rico, Canada, and Australia, with participants randomized between placebo and simufilam (100 mg twice daily)

Shares of Cassava Sciences, Inc. (SAVA) fell more than 12% in pre-market trading on Friday, following the company’s announcement of a $40 million settlement with the U.S. Securities and Exchange Commission (SEC).The penalty, related to misleading claims made about its Alzheimer’s drug trials, drew significant attention from retail investors, making SAVA the top trending ticker on Stocktwits by 9 a.m. ET.The SEC charged Cassava and two former executives — founder and former CEO Remi Barbier and former Senior VP of Neuroscience Lindsay Burns — with making misleading statements in 2020 regarding the results of a clinical trial for their experimental Alzheimer's treatment, simufilam.The regulator alleged that the company claimed the drug "significantly improved patient cognition," while failing to disclose that full patient data showed "no measurable cognitive improvement" in episodic memory.Hoau-Yan Wang, a professor at the City University of New York Medical School who worked with Cassava to develop the drug, was also charged with manipulating trial data.Cassava agreed to the settlement without admitting or denying the charges."Cassava is pleased to put this matter behind us," CEO Richard Barry said in a statement. "We can now focus all of our attention on completion of the ongoing Phase 3 trials of simufilam.”<figure class="image"><a href="https://stocktwits.com/symbol/SAVA"><img style="aspect-ratio:1320/324;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/SAVA_stock_sentiment_and_message_volume_Sep_27_pre_market_d6f4e89110.png" alt="SAVA stock sentiment and message volume Sep 27 pre-market.png" width="1320" height="324"></a><figcaption>SAVA stock sentiment and message volume Sep 27 pre-market</figcaption></figure>Despite the stock’s sharp decline early on Friday, retail sentiment for SAVA remained ‘bullish’.Many investors on Stocktwits saw the settlement as a non-event, with some noting that the $40 million had already been set aside for the penalty.One user remarked, “We knew it was coming… This doesn’t take anyone by surprise.”<stembedurl>https://stocktwits.com/xNovah/message/587331181</stembedurl>Others were even more optimistic, focusing on the company’s Phase 3 trials, adding that with the SEC issue resolved, the path is clear for Cassava to move ahead with its clinical trials and potential FDA approval.<stembedurl>https://stocktwits.com/TagyouRit/message/587306764</stembedurl>Earlier this week, Cassava announced that a Data and Safety Monitoring Board completed a third interim safety review of simufilam, recommending that the ongoing Phase 3 studies continue without modifications.Chief Medical Officer Jim Kupiec stated that the company is on track to announce top-line data for the 12-month Phase 3 study by the end of 2024.Despite recent setbacks, SAVA stock is still up more than 40% year-to-date. Retail investors appear to be holding out hope for a potential breakthrough as the company moves closer to critical trial results later this year.Read next: <a href="https://stocktwits.com/news/markets/equity/djt-stock-falls-after-co-founder-litinsky-slashes-stake/c7CUFDdR3G">Trump Media Stock Faces Pressure As Co-Founder Nearly Exits Stake: Retail Still Bullish</a> &nbsp;

The SEC said the company made misleading statements in 2020 regarding the results of a clinical trial for their experimental Alzheimer's treatment, simufilam. 

Cassava Sciences Stock Slides After $40M SEC Settlement Over Misleading Alzheimer’s Trial Claims, Captures Retail Spotlight

Many investors on Stocktwits saw the settlement as a non-event, with some noting that the penalty had already been priced in. 

Africa-based e-commerce platform Jumia Technologies’ shares dove nearly 48% on Tuesday after the firm announced its intention to raise funds by issuing over 20.22 million American Depositary Shares (ADS).The firm intends to use the proceeds to help support customer acquisition, expansion of supplier base, scaling its logistics network and improving marketing and vendor technology. It also cited general corporate purposes.However, retail investors are shrugging-off the fundraise news while concentrating on its improving operating metrics.Jumia Technologies’ Q2 revenue declined 17% year-over-year (YoY) to $36.50 million but operating loss narrowed to $20.20 million compared to $22.10 million in the same period a year ago.The firm said its quarterly cash burn declined 55% driven by effective cost management and reduction in finance costs. Its finance costs for the second quarter were mainly influenced by losses recognized on the sale of financial assets. Jumia also reported a 35% jump in its gross merchandise value (GMV) at $170.10 million (constant currency basis).Notably, 67% of the company’s liquidity position was held in U.S. dollars as of the second quarter of 2024. Jumia said it continues to refine its cash repatriation strategy.Following the announcement, retail sentiment shifted into the ‘bullish’ territory (76/100) from the bearish zone, while message volumes hit a one-year high.<figure class="image"><a href="https://stocktwits.com/symbol/JMIA"><img style="aspect-ratio:1572/450;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_08_06_at_12_34_50_PM_47e543ee3d.png" alt="Jumia Technologies’ sentiment meter as of 12:09 p.m. EST on August 06, 2024" width="1572" height="450"></a><figcaption>Jumia Technologies’ sentiment meter as of 12:09 p.m. EST on August 06, 2024</figcaption></figure>The firm is also attracting more quality customers, showing a 262 basis points YoY improvement in repurchase rates during the first quarter of 2024.According to the company’s analysis, 36% of new customers who placed an order for a product or a service on its platform in Q1 completed a second purchase within 90 days. “This represents an improvement compared to 33% of new customers from the first quarter of 2023, who reordered within 90 days,” it said.Jumia now projects an increase in both orders and GMV in 2024, excluding the potential impact of foreign exchange. Stocktwits bulls are betting on the long-term prospects of the firm while expecting continued improvements in its underlying business trends. &nbsp;<figure class="image"><a href="https://stocktwits.com/glasshouse56/message/581969568"><img style="aspect-ratio:1550/310;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_08_06_at_12_38_52_PM_a7683afc99.png" alt="Stocktwits user glasshouse56's post on Jumia Technologies" width="1550" height="310"></a><figcaption>Stocktwits user glasshouse56's post on Jumia Technologies</figcaption></figure>

Jumia Technologies Falls 48% After Fundraise Disclosure But Retail Focuses On Improving Operating Metrics

Jumia Technologies will be issuing over 20.22 million American Depositary Shares turning Wall Street against it. But retail investors believe the firm’s improving metrics and newfound liquidity lays the foundation for better long-term prospects.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Current Price	$5.67
Prev Close	$5.62
Open	$5.63
Dividend Yield	N/A
50-Day Moving Average	$5.94
Beta	N/A
Avg. Volume	40.66M
PE Ratio	N/A

52-Week High	$10.92
52-Week Low	$5.23
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

ULTY
YieldMax Ultra Option Income Strategy ETF

Feed

News

Sentiment

Fundamentals

Info

Latest ULTY News

ULTY YieldMax Ultra Option Income Strategy ETF